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Background: Impaired cognitive control in individuals with attention-deﬁcit/hyperactivity
disorder (ADHD) may be related to a prefrontal cortical glutamatergic deﬁcit.We assessed
the glutamate level in the left and the right midfrontal region including the anterior cingu-
late cortex in adults with ADHD and healthy controls. Methods: Twenty-nine adults with
ADHD and 38 healthy controls were included.We used Proton Magnetic Resonance Imag-
ing with single voxel point-resolved spectroscopy to measure the ratio of glutamate to
creatine (Glu/Cre) in the left and the right midfrontal region in the two groups. Results:The
ADHD group showed a signiﬁcant reduction of Glu/Cre in the left midfrontal region com-
pared to the controls. Conclusion: The reduction of Glu/Cre in the left midfrontal region
in the ADHD group may reﬂect a glutamatergic deﬁcit in prefrontal neuronal circuitry in
adults with ADHD, resulting in problems with cognitive control.
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INTRODUCTION
Attention-deﬁcit/hyperactivity disorder (ADHD) is a neurode-
velopmental disorder with three distinct clinical subtypes; the
inattentive, the hyperactive/impulsive, and the combined type.
The pooled prevalence of children and adolescents with ADHD
worldwide is estimated to 5.3% (Polanczyk et al., 2007). Approx-
imately 65% of affected children show persistent symptoms with
functional impairment into adulthood (Faraone et al., 2006),
whereas some children experience an improvement or even com-
plete elimination of symptoms during adolescence, which may
be explained by a delay and later catch-up in cortical maturation
(Shaw et al., 2007). Adults with persisting ADHD thus may repre-
sent a subgroup with symptoms caused by other neurobiological
underpinnings than a mere delay of cortical development.
Although ADHD is regarded as a neuropsychologically hetero-
geneous disorder (Willcutt, 2005;Doyle, 2006; Sonuga-Barke et al.,
2010), deﬁcits in cognitive control are considered key impairments
in this disorder. A cognitive control process presumably taps the
executive control network (Hugdahl et al., 2009), which is one of
the three networks described in the attentional networks model
(Fan et al., 2005, 2009). The anterior cingulate cortex (ACC) is
part of the executive control network (Posner and Rothbart, 2007)
and its function is essential for the exertion of cognitive control
(Bush et al., 2000; Carter andVanVeen, 2007). Studies using func-
tional neuroimaging (Bush et al., 2005) suggest that a dysfunction
in the dorsal ACC plays a role in the pathophysiology of ADHD.
The ACC has a high density of glutamate receptors (Vogt,
2009), and glutamate may be an important metabolite for cog-
nitive functions (O’neill and Dix, 2007). Glutamatergic neuro-
transmission may prove a key target in the treatment of sev-
eral psychiatric disorders (Javitt, 2004), and growing research
on the psychopharmacology of glutamate receptor agonists and
antagonists documents an increasing interest for its therapeu-
tic use in psychiatry (Parsons et al., 2005; Krystal et al., 2010;
Lesage and Steckler, 2010). A recent study (Ludolph et al., 2010)
highlights the role of glutamate in ADHD by demonstrating
that the norepinephrine reuptake inhibitor atomoxetine, which
is effective against ADHD symptoms, is also an NMDA receptor
antagonist.
Magnetic resonance spectroscopy (MRS) is a non-invasive
method to measure metabolites in the brain (Graaf, 2007). Earlier
MRS studies of persons with ADHD have focused on metabo-
lites like choline compounds,N -acetyl aspartate (NAA), glutamate
(Glu), and glutamine (Gln; Perlov et al., 2009). A synthesis of Glu
and Gln (Glx) has often been used, because the separation of Glu
and Gln proves difﬁcult at lower ﬁeld strengths. The separation of
Glu from Gln is, however, possible at ﬁeld strengths as low as 2 T if
using a short echo time (TE) and the linear combination of model
(LCModel; Provencher, 1993, 2001). The concentration of total
creatine (Cre) is relatively constant, which is why this metabolite
has often been used as an internal concentration reference (Graaf,
2007; Dager et al., 2008).
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A recent meta-analysis including 16 MRS studies of partic-
ipants with ADHD concluded with altered Glx/Cre, NAA/Cre,
and Choline/Cre ratios (Perlov et al., 2009) in patients relative
to controls. However, only three of these studies included adults.
To our knowledge, a total of seven MRS studies of adults with
ADHD have been published (Hesslinger et al., 2001; Perlov et al.,
2007, 2010; Colla et al., 2008; Kronenberg et al., 2008; Ferreira
et al., 2009; Rusch et al., 2010), of which the ACC has been
examined speciﬁcally in four studies. Although a signiﬁcantly
reduced Glx/Cre ratio in ACC was reported in one study (Perlov
et al., 2007), other ﬁndings have been inconsistent across studies,
possibly explained by heterogeneity of the sample and different
spectroscopic methodologies.
In this MRS study we aimed at focusing on the midfrontal
region due to the assumed importance of the ACC for cognitive
control functions,which in turn are central in the pathophysiology
of ADHD. Glutamate is essential in neurotransmission in the ACC
andmay prove a keymetabolite in cognitive functions, andwe thus
hypothesized that adults with ADHD would show a reduction of
the glutamate level in the midfrontal region compared with the
controls.
MATERIALS AND METHODS
PARTICIPANTS
The sample of 29 participants with ADHD and 38 healthy con-
trols was recruited from the Norwegian ADHD-project in Bergen.
The ADHD group consisted of 15 men and 14 women with mean
age 32.9 years (SD= 7.1, age range 21–48 years) and mean Wech-
sler Abbreviated Scale of Intelligence (WASI) IQ 110.6 (SD= 14.3,
IQ range 78–128). The control group consisted of 15 men and
23 women with mean age 29.8 years (SD= 6.5, age range 21–
41 years) and mean WASI-IQ 116.3 (SD= 9.4, IQ range 96–136).
The groups did not differ signiﬁcantly neither in their composi-
tion of sex (χ2 = 1.00; df = 1; p = 0.32), nor with respect of means
of age [t (65)= 1.84; p = 0.07] or means of IQ [t (65)=−1.97;
p = 0.053].
All patients had been diagnosed according to ICD-10 or DSM-
IV criteria for hyperkinetic disorder/ADHD by a psychiatrist or
psychologist before the inclusion in theNorwegianADHD-project
in Bergen. Controls were randomly selected from the compari-
son group in the Norwegian ADHD-project in Bergen (Halmoy
et al., 2009), recruited from the database of the Medical Birth
Registry of Norway. Details concerning the recruitment proce-
dure are described in recent publications by the Bergen group
(Johansson et al., 2008; Halleland et al., 2009; Halmoy et al.,
2009). All participants in both groups were interviewed with the
ADHD module of K-SADS (Kaufman et al., 1997) adjusted to
adults, administered by an experienced psychiatrist (Margaretha
Dramsdahl). Based on symptoms reported in childhood, the par-
ticipants were categorized into the following subgroups: seven
with inattentive type, three with hyperactive/impulsive type and
19 participants with combined type. According to the present
symptoms, however, nine participants had an inattentive type, one
had symptoms of the hyperactive/impulsive type and 19 partici-
pants had a combined type. The Adult ADHD Self-Report Scale
(ASRS-18; Kessler et al., 2005) was used to determine current
ADHD symptoms in both groups. It consists of two subscales, one
scale measuring inattentive symptoms, the other scale measuring
hyperactive/impulsive symptoms.
The ADHD group included both medication naïve as well as
medicated participants. The 16 patients medicated with stimu-
lants (n = 15) or atomoxetine (n = 1) were instructed to withhold
medication 48 h prior to testing to reduce the possible inﬂuence of
medication. Nine participants followed this instruction, whereas
ﬁve reduced the dosage during the last 48 h (including the sole
participant on atomoxetine), and two participants continued their
ordinary medication. Thirteen of the participants in the ADHD
group had not used stimulants or atomoxetine during the past
6months.
Participants with ADHD consisted of 23 right-handed and
6 left-handed participants, whereas 33 right-handed and 5 left-
handed controls were included. Handedness was determined by
the hand that the subject preferred to draw and write with.
Exclusion criteria for both groups were current severe psy-
chiatric axis I disorder or substance abuse, epilepsy, or other
neurological or physical disease with cognitive impairment. Par-
ticipants with a lifetime history of developmental delay, premature
birth before 34weeks of gestational age, or IQ below 70 were
neither included. To ensure as representative ADHD sample as
possible, we included participants with current mild psychiatric
comorbidity (anxiety disorders and mild depressive symptoms).
Eleven of the ADHD participants had diagnosis of an anxiety dis-
order (panic disorder, agoraphobia, social phobia, and/or speciﬁc
phobia), two had a depressive disorder or dysthymia, and three
ADHD participants had diagnosis of both anxiety and depres-
sive disorder. No participant, however, reported ongoing, severe
symptoms at the time for the MR scanning. Further exclusion
criteria for the controls were lifetime history of ADHD, cur-
rent ADHD symptoms (score >36 on ASRS-18, or >20 on one
of the two subscales), or ﬁrst-degree relatives (parents, children,
siblings) with ADHD. Three of the controls had diagnosed spe-
ciﬁc phobia, but none had ongoing symptoms at the time of
scanning.
Written informed consent was obtained from all participants
after receiving detailed information about the procedure. The
study was approved by the Norwegian Regional Medical Research
Ethics Committee West IRB #3 (FWA00009490, IRB00001872).
MR SPECTROSCOPY
1H-MR scanning was performed with a 3.0-T GE Signa HDx scan-
ner, using an eight-channel head coil. Single voxel point-resolved
spectroscopy (PROBE-PRESS) was used with the following para-
meters: TE= 35ms, TR= 1500ms. Line-width was less than 8Hz
and water suppression level at least 94%.
A T 1-weighted image using a 3D Fast Spoiled Gradient Recall
sequence (TE= 14ms, TR= 400ms, TI= 500ms; scan matrix:
256× 256; ﬁeld of view of 256mm× 256mm, 188 sagittal slices
of 1mm thickness) was acquired to position the slices parallel to
the line connecting the lowest edge of the splenium and the ros-
trum of the CC. In addition to the T 1-weighted image an axial
T 2-weighted image was acquired prior to the proton MRS imag-
ing sequences. The T 2-weighted image was used as reference for
cerebrospinal ﬂuid (CSF) within the area of interest to avoid CSF
contamination of the MRS voxel.
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Voxel size was 20mm× 20mm× 20mm localized in the left
and the right midfrontal region including the dorsal ACC. The
position of the MRS voxel was parallel to the CC,midway between
the upper part of the mid-body of the CC, and the most ante-
rior part of the genu, close against the edge of the white matter in
the CC (Figure 1). Scanning was performed with the MRS voxel
localized ﬁrst in the left and then in the right midfrontal region.
DATA ANALYSIS
The ratio of Glu to Cre were estimated by LCModel software ver-
sion 6.2-1A using a simulated basis-set for a TE of 35ms, delivered
by Provencher (2011). LCModel automatically quantiﬁes in vivo
spectra, avoiding analyses of individual peaks or use of any subjec-
tive inﬂuenced model. Estimated SD (Cramér–Rao lower bounds)
below 20% were accepted, which is a rough criterion for estimates
of acceptable reliability (Provencher, 2011).
FIGURE 1 |The position of the 20-mm×20-mm×20-mm voxel in the
midfrontal region.
All statistical analyses were made by general linear model
(GLM) using the Statistica 8 software (http://www.statsoft.com/).
Group comparisons were made between the ADHD and control
group and between the left and right side in a multivariate analysis
of variance (MANOVA) including Glu/Cre left and Glu/Cre right
as dependent variables and group as categorical variable. In order
to control for any effect of covariates, the data were reanalyzed
with multivariate analysis of covariance (MANCOVA) including
Glu/Cre left and Glu/Cre right as dependent factors, group, sex,
and handedness as categorical predictors, and age and IQ as con-
tinuous predictors. Since none of the interactions were signiﬁcant,
we removed the interaction terms before re-running the analysis
twice with Glu/Cre left and Glu/Cre right, respectively, as depen-
dent variables, group as categorical predictor, and sex, handedness,
age, and IQ as covariates. Medication and comorbidity were not
included as covariates in the GLM analyses, since these variables
had implications mainly for the ADHD group, and some of the
subgroups would be very small or even give empty cells in the sta-
tistical design. Thus, to investigate the effect of comorbidity and
medication we did independent t -tests of the ADHD group with
Glu/Cre ratio left side as dependent variable and comorbidity and
medication, respectively, as grouping variables. As a last analysis
we correlated the value of Glu/Cre in the leftmidfrontal region and
scores of the two ASRS subscales to explore a possible association.
RESULTS
All spectra of the 67 included participants were of good quality
(see Figure 2 for a representative spectrum).
FIGURE 2 | A representative spectrum indicating position of peaks and calculation of signal-to-noise ratios.
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The MANOVA including Glu/Cre left and Glu/Cre right as
dependent variables and group as categorical variable revealed sig-
niﬁcant main effects of group and of side (Table 1; Figure 3). The
mean Glu/Cre ratio was reduced in the ADHD group compared to
the control group and the difference was only signiﬁcant in the left
midfrontal area. The mean Glu/Cre ratio was signiﬁcantly lower
in left midfrontal region compared to right midfrontal region in
both groups. The MANCOVA including Glu/Cre left and Glu/Cre
right as dependent factors, group, sex, and handedness as categor-
ical predictors, and age and IQ as continuous predictors, revealed
a signiﬁcant main effect of group, but no longer any signiﬁcant
side effect (Table 2). Age and IQ had each a signiﬁcant main effect,
but,more importantly, no interactions between the factors became
signiﬁcant.
The ANCOVAs with Glu/Cre left and Glu/Cre right, respec-
tively, as dependent variables, group as categorical predictor, and
sex, handedness, age, and IQ as covariates conﬁrmed a main effect
of group at the left side, but not at the right (see Table A2 in
Appendix).
In order to further elaborate the signiﬁcant group effect in
the left midfrontal area, detected by the MANOVA, follow up
statistics were performed for this region, only. The t -test of the
ADHD group with Glu/Cre ratio left side as dependent vari-
able and comorbidity as grouping variable revealed signiﬁcant
Table 1 | Main and interaction effects of general linear model including
glutamate/creatine ratios at left and right side as dependent variables
and group (ADHD, control) as categorical predictors.
SS df MS F p
Group 0.269 1 0.269 8.34 0.005*
Side 0.288 1 0.288 13.48 0.000*
Side×group 0.009 1 0.009 0.43 0.513
FIGURE 3 | Mean glutamate to creatine (Glu/Cre) ratio in the left and
right midfrontal region in the attention-deficit/hyperactivity disorder
(ADHD) and control groups. Vertical bars denotes 95% conﬁdence
intervals.
lower Glu/Cre value in the ADHD group without comorbidity
compared to the ADHD group with comorbidity (see Table A1 in
Appendix). The t -test of the ADHD group including medication
as grouping variable showed no signiﬁcant difference in Glu/Cre
ratio at left side between themedicated andnon-medicatedADHD
participants (see Table A1 in Appendix).
The correlation between the symptoms of severity (ASRS
scores) and the value of Glu/Cre in the left midfrontal region of
the ADHD participants revealed no signiﬁcant correlation. When
including the controls and thus increasing the statistical power, a
signiﬁcant negative correlation between inattentive symptoms and
Glu/Cre level was revealed (r =−0.274, p = 0.025). There was no
signiﬁcant correlation between the hyperactive/impulsive scores
and the level of Glu/Cre in left midfrontal region (r =−0.107,
p = 0.39).
DISCUSSION
The main ﬁnding of a reduced ratio of Glu/Cre in the left mid-
frontal region in participants with ADHD supports the hypothesis
of ADHDas a hypoglutamatergic condition (Carlsson, 2001). Glu-
tamate is an important neurotransmitter in cognitive processes
(Van Wageningen et al., 2009, 2010) and seems to have a cen-
tral role in neurotransmission in the ACC (Bozkurt et al., 2005;
Yang et al., 2006). The dorsal ACC, in turn, plays a crucial role
in the exertion of cognitive control (Bush et al., 2000; Carter and
Van Veen, 2007), and a glutamatergic deﬁcit in the midfrontal
region including the dorsal ACC, may contribute to the impaired
cognitive control in persons with ADHD.
The hypothesis that a dysregulation of catecholaminergic neu-
rotransmission contributes to the development of symptoms typ-
ical for ADHD has been supported from different research areas,
notably frompharmacological studies of psychostimulants (Staller
and Faraone, 2007; Genro et al., 2010). The exact modes of
action of human ADHD-medication, however, are still unknown
(Solanto, 1998; Challman and Lipsky, 2000; Cornforth et al.,
2010). Although changes in dopamine or norepinephrine levels
may primarily mediate the effect of psychostimulants, the puta-
tive monoamine dysfunction in ADHD may also derive from an
impaired glutamatergic transmission (Carlsson, 2001).
Our results partially replicate and extend previous studies of
brain glutamate levels in persons with ADHD, but comparisons
between studiesmay be difﬁcult because of methodological and/or
Table 2 | Main effects of general linear model including
glutamate/creatine ratios at left and right side as dependent
variables, group (ADHD, control), sex (man, woman), and handedness
(left, right) as categorical predictors, and age and IQ as continuous
predictors.
SS df MS F p
Group 0.108 1 0.108 4.484 0.039*
Side 0.005 1 0.005 0.246 0.622
Sex 0.009 1 0.009 0.358 0.552
Age 0.175 1 0.175 7.264 0.009*
IQ 0.219 1 0.219 9.097 0.004*
Handedness 0.074 1 0.074 3.084 0.084
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positional differences. One study concluding with signiﬁcantly
reduced Glx/Cre in the right ACC (Perlov et al., 2007) used
multi-voxel chemical shift imaging (CSI) instead of single voxel
spectroscopy. A recent single voxel MRS study reported increased
glutamate concentration in the left ACC (Rusch et al., 2010), with
the voxel of measurement positioned in the rostral part of ACC,
anterior to the genu of the CC, and not in the dorsal, “cogni-
tive” part. Furthermore, women were only included when ADHD
was comorbid with a borderline personality disorder, making it
difﬁcult to draw conclusions about the speciﬁc impact of ADHD.
In addition to the diagnostic effect, we also revealed a signif-
icant main effect of side with reduced Glu/Cre in the left mid-
frontal area. A difference in Glu/Cre value between the left and
the right side may indicate a lateralization of the frontal region
including the dorsal part of the ACC. Reports of morphological
differences between left and right midfrontal regions support this
hypothesis, with the paracingulate sulcus more commonly found
pronounced in the left compared to the right hemisphere (Huster
et al., 2007; Fornito et al., 2008). The signiﬁcant difference between
the Glu/Cre in left and right midfrontal region disappeared, how-
ever, after correction for the covariates sex, handedness, age, and
IQ (see Table 2).
The re-analysis showed a signiﬁcant main effect of age. This
ﬁnding is in accordance with earlier report of a slight decrease of
Glu concentration in the ACC with increasing age (Schubert et al.,
2004).
The exploratory ﬁnding of a signiﬁcant negative correlation
between inattentive symptoms and Glu/Cre level may support
the presumption of glutamate in the midfrontal region as an
important factor of cognitive control.
This study has several limitations. First, our sample is small
with seven predictive variables (group, sex, handedness, age, IQ,
medication, and comorbidity), and replication studies are thus
necessary. We here present a representative ADHD sample, which
increased the numbers of variables and possible confounding fac-
tors. The mean IQ value was lower in the ADHD group compared
to the control group,but not signiﬁcantly different. Cognitive difﬁ-
culties in neurodevelopmental disorders like ADHD are, however,
of such pervasive nature that matching fully for IQ is likely to
reduce the representativeness of the ADHD group (Dennis et al.,
2009). Likewise, any correction for comorbidity would result in a
non-representative ADHD group. The signiﬁcant lower Glu/Cre
value in the ADHD group without comorbidity compared to the
ADHD group with comorbidity support the presumption that
comorbidity cannot explain the main ﬁnding of reduced Glu/Cre
ratio at left side in the ADHD group.
Second, the participants were on different medication regimes,
and even if medication did not seem to have any signiﬁcant inﬂu-
ence in our study (see Table A1 in Appendix), it may have an
inﬂuence on the neurochemistry and the neuronal activity. Inclu-
sion of only medication naïve participants would be a way to
eliminate a possible confounding effect of medication.
Third, changes in the Glu/Cre ratio may be a result of changes
in the concentration of Cre.As an internal reference the concentra-
tion of Cre is supposed to be constant, and no changes have been
reported with age, at least not before the age of 60 years (Saun-
ders et al., 1999). The concentration of Cre, however, may vary in
pathological conditions, such as mood disorders (Capizzano et al.,
2007), brain tumors (Yerli et al., 2007), or ischemia (Karaszewski
et al., 2010), and even small changes in the Cre value may inﬂu-
ence the ratio of Glu to Cre. However, we analyzed the Glu/Cre
ratio, because the ratio is less sensitive to relaxation and partial
volume effects than the absolute concentrations of metabolites
(Provencher,2011).Unknownunits of the absolute concentrations
were another reason for using the ratios.
A last limitation is the possible confounding factors of offsets
of the chemical shifts, as well as different distribution of CSF and
gray and white matter in the voxels. We consider, however, the
voxel size large enough to minimize these effects, but cannot elim-
inate a contribution of these factors to the differences between the
sides, as well as the groups.
In conclusion, our results reﬂect a hypoglutamatergic condi-
tion in the midfrontal regions of adults with ADHD, which may
cause impaired cognitive control and a dysfunctional top-down
regulation. More studies mapping the glutamatergic pathways and
their interaction with other transmitters in persons with ADHD
would help to further reveal the underlying neurobiology of the
disorder.
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APPENDIX
Table A1 | Independent t -tests of the ADHD group (n =29) with glutamate/creatine ratio left side as dependent variable, and comorbidity and
medication, respectively, as grouping variables.
Glu/Cre left t -value df p
Mean – Comorb. Yes (n=16) 1.548 2.167 27 0.039*
Mean – Comorb. No (n=13) 1.419
Mean – Medic. Yes (n=16) 1.469 −0.753 27 0.458
Mean – Medic. No (n=13) 1.517
Table A2 | Main effects of general linear model including glutamate/creatine ratios at left side and right side, respectively, as dependent
variables, group (ADHD, control) as categorical predictor, and sex (man, woman), handedness (left, right), age, and IQ as covariates.
Glu/Cre left Glu/Cre right
SS df MS F p SS df MS F p
Group 0.150 1 0.150 7.469 0.008* 0.085 1 0.085 3.279 0.075
Sex 0.002 1 0.002 0.093 0.761 0.022 1 0.022 0.845 0.362
Age 0.165 1 0.165 8.215 0.006* 0.085 1 0.085 3.279 0.075
IQ 0.153 1 0.153 7.602 0.008* 0.097 1 0.097 3.737 0.058
Handedness 0.091 1 0.091 4.523 0.038* 0.029 1 0.029 1.122 0.294
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